Tokyo Tape
Sign in
← Baby calendar

Annual report

7363.TEDINET S100QI7G
Period2022-01-01 → 2022-12-31
Filed2023-03-30
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 84
MetricValuePeriodScopeSource row
Revenue¥1.1bn2022-01-01 → 2022-12-31StandaloneNet sales
Revenue¥1.0bn2021-01-01 → 2021-12-31StandaloneNet sales
Revenue¥894m2020-01-01 → 2020-12-31dStandaloneNet sales (5-year summary)
Revenue¥600m2019-01-01 → 2019-12-31dStandaloneNet sales (5-year summary)
Revenue¥488m2018-01-01 → 2018-12-31dStandaloneNet sales (5-year summary)
Operating income¥38m2022-01-01 → 2022-12-31StandaloneOperating income
Operating income¥129m2021-01-01 → 2021-12-31StandaloneOperating income
Ordinary income¥37m2022-01-01 → 2022-12-31StandaloneOrdinary income
Ordinary income¥116m2021-01-01 → 2021-12-31StandaloneOrdinary income
Ordinary income¥96m2020-01-01 → 2020-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥33m2019-01-01 → 2019-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥17m2018-01-01 → 2018-12-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥37m2022-01-01 → 2022-12-31StandaloneIncome before income taxes
Profit before tax¥116m2021-01-01 → 2021-12-31StandaloneIncome before income taxes
Net income¥21m2022-01-01 → 2022-12-31StandaloneProfit loss
Net income¥75m2021-01-01 → 2021-12-31StandaloneProfit loss
Net income¥62m2020-01-01 → 2020-12-31dStandaloneNet income loss (5-year summary)
Net income¥71m2019-01-01 → 2019-12-31dStandaloneNet income loss (5-year summary)
Net income−¥19m2018-01-01 → 2018-12-31dStandaloneNet income loss (5-year summary)
Total assets¥1.1bnat 2022-12-31StandaloneAssets
Total assets¥1.4bnat 2021-12-31StandaloneAssets
Total assets¥502mat 2020-12-31dStandaloneTotal assets (5-year summary)
Total assets¥373mat 2019-12-31dStandaloneTotal assets (5-year summary)
Total assets¥251mat 2018-12-31dStandaloneTotal assets (5-year summary)
Total liabilities¥324mat 2022-12-31StandaloneLiabilities
Total liabilities¥486mat 2021-12-31StandaloneLiabilities
Net assets / equity¥806mat 2022-12-31StandaloneNet assets
Net assets / equity¥872mat 2021-12-31StandaloneNet assets
Net assets / equity¥346mat 2020-12-31dStandaloneNet assets
Net assets / equity¥284mat 2019-12-31dStandaloneNet assets (5-year summary)
Net assets / equity¥160mat 2018-12-31dStandaloneNet assets (5-year summary)
Cash and deposits¥716mat 2022-12-31StandaloneCash and deposits
Cash and deposits¥1.0bnat 2021-12-31StandaloneCash and deposits
Cash & equivalents¥716mat 2022-12-31StandaloneCash and cash equivalents
Cash & equivalents¥1.0bnat 2021-12-31StandaloneCash and cash equivalents
Cash & equivalents¥237mat 2020-12-31dStandaloneCash and cash equivalents
Cash & equivalents¥173mat 2019-12-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥68mat 2018-12-31dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow−¥3m2022-01-01 → 2022-12-31StandaloneNet cash provided by used in operating activities
Operating cash flow¥96m2021-01-01 → 2021-12-31StandaloneNet cash provided by used in operating activities
Operating cash flow¥148m2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥68m2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥39m2018-01-01 → 2018-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥134m2022-01-01 → 2022-12-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥17m2021-01-01 → 2021-12-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥78m2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥8m2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥23m2018-01-01 → 2018-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow−¥189m2022-01-01 → 2022-12-31StandaloneNet cash provided by used in financing activities
Financing cash flow¥726m2021-01-01 → 2021-12-31StandaloneNet cash provided by used in financing activities
Financing cash flow−¥17m2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥45m2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow−¥22m2018-01-01 → 2018-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥22.942022-01-01 → 2022-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥87.662021-01-01 → 2021-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥83.392020-01-01 → 2020-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥98.42019-01-01 → 2019-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-282018-01-01 → 2018-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥22.42022-01-01 → 2022-12-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥78.912021-01-01 → 2021-12-31StandaloneDiluted earnings per share (5-year summary)
Net assets per share¥893.39at 2022-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥955.38at 2021-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥465.52at 2020-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥382.13at 2019-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥232.75at 2018-12-31dStandaloneNet assets per share (5-year summary)
Equity ratio71.3%at 2022-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio64.2%at 2021-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio68.8%at 2020-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio76.0%at 2019-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio63.7%at 2018-12-31dStandaloneEquity to asset ratio (5-year summary)
ROE2.5%2022-01-01 → 2022-12-31StandaloneRate of return on equity (5-year summary)
ROE12.3%2021-01-01 → 2021-12-31StandaloneRate of return on equity (5-year summary)
ROE19.6%2020-01-01 → 2020-12-31dStandaloneRate of return on equity (5-year summary)
ROE31.9%2019-01-01 → 2019-12-31dStandaloneRate of return on equity (5-year summary)
Shares issued941,700at 2022-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued912,200at 2021-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued743,000at 2020-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued1,486at 2019-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued1,372at 2018-12-31dStandaloneTotal number of issued shares (5-year summary)
Employees56at 2022-12-31StandaloneNumber of employees
Employees49at 2021-12-31StandaloneNumber of employees
Employees45at 2020-12-31dStandaloneNumber of employees
Employees31at 2019-12-31dStandaloneNumber of employees
Employees31at 2018-12-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 38
SegmentItemPeriodValue
Developing Management Support Solution Business For Obstetrics And Gynecologyreportable segmentcapex2022-01-01 → 2022-12-31¥6m
Developing Management Support Solution Business For Obstetrics And Gynecologyreportable segmentdepreciation2022-01-01 → 2022-12-31¥9m
Developing Management Support Solution Business For Obstetrics And Gynecologyreportable segmentemployeesat 2022-12-3122 pure
Developing Management Support Solution Business For Obstetrics And Gynecologyreportable segmentrevenue2022-01-01 → 2022-12-31¥285m
Developing Management Support Solution Business For Obstetrics And Gynecologyreportable segmentrevenue external2022-01-01 → 2022-12-31¥285m
Developing Management Support Solution Business For Obstetrics And Gynecologyreportable segmentsegment assetsat 2022-12-31¥85m
Developing Management Support Solution Business For Obstetrics And Gynecologyreportable segmentsegment profit2022-01-01 → 2022-12-31¥21m
Media Business For Pregnancy Childbirth And Childcarereportable segmentcapex2022-01-01 → 2022-12-31¥113m
Media Business For Pregnancy Childbirth And Childcarereportable segmentdepreciation2022-01-01 → 2022-12-31¥11m
Media Business For Pregnancy Childbirth And Childcarereportable segmentemployeesat 2022-12-3129 pure
Media Business For Pregnancy Childbirth And Childcarereportable segmentrevenue2022-01-01 → 2022-12-31¥800m
Media Business For Pregnancy Childbirth And Childcarereportable segmentrevenue external2022-01-01 → 2022-12-31¥800m
Media Business For Pregnancy Childbirth And Childcarereportable segmentsegment assetsat 2022-12-31¥244m
Media Business For Pregnancy Childbirth And Childcarereportable segmentsegment profit2022-01-01 → 2022-12-31¥207m
Total Of Reportable Segments And Otherssegment totalcapex2022-01-01 → 2022-12-31¥119m
Total Of Reportable Segments And Otherssegment totaldepreciation2022-01-01 → 2022-12-31¥20m
Total Of Reportable Segments And Otherssegment totalrevenue2022-01-01 → 2022-12-31¥1.1bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-01-01 → 2022-12-31¥1.1bn
Total Of Reportable Segments And Otherssegment totalsegment assetsat 2022-12-31¥329m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-01-01 → 2022-12-31¥227m
Developing Management Support Solution Business For Obstetrics And Gynecologyreportable segmentcapex2021-01-01 → 2021-12-31¥4m
Developing Management Support Solution Business For Obstetrics And Gynecologyreportable segmentdepreciation2021-01-01 → 2021-12-31¥11m
Developing Management Support Solution Business For Obstetrics And Gynecologyreportable segmentrevenue2021-01-01 → 2021-12-31¥308m
Developing Management Support Solution Business For Obstetrics And Gynecologyreportable segmentrevenue external2021-01-01 → 2021-12-31¥308m
Developing Management Support Solution Business For Obstetrics And Gynecologyreportable segmentsegment assetsat 2021-12-31¥88m
Developing Management Support Solution Business For Obstetrics And Gynecologyreportable segmentsegment profit2021-01-01 → 2021-12-31¥19m
Media Business For Pregnancy Childbirth And Childcarereportable segmentcapex2021-01-01 → 2021-12-31¥9m
Media Business For Pregnancy Childbirth And Childcarereportable segmentdepreciation2021-01-01 → 2021-12-31¥8m
Media Business For Pregnancy Childbirth And Childcarereportable segmentrevenue2021-01-01 → 2021-12-31¥734m
Media Business For Pregnancy Childbirth And Childcarereportable segmentrevenue external2021-01-01 → 2021-12-31¥734m
Media Business For Pregnancy Childbirth And Childcarereportable segmentsegment assetsat 2021-12-31¥96m
Media Business For Pregnancy Childbirth And Childcarereportable segmentsegment profit2021-01-01 → 2021-12-31¥282m
Total Of Reportable Segments And Otherssegment totalcapex2021-01-01 → 2021-12-31¥14m
Total Of Reportable Segments And Otherssegment totaldepreciation2021-01-01 → 2021-12-31¥19m
Total Of Reportable Segments And Otherssegment totalrevenue2021-01-01 → 2021-12-31¥1.0bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-01-01 → 2021-12-31¥1.0bn
Total Of Reportable Segments And Otherssegment totalsegment assetsat 2021-12-31¥184m
Total Of Reportable Segments And Otherssegment totalsegment profit2021-01-01 → 2021-12-31¥301m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 836
ItemContextValueUnit
Decrease increase in inventories ope cfPrior1YearDuration_NonConsolidatedMember762000JPY
Decrease increase in inventories ope cfCurrentYearDuration_NonConsolidatedMember-2943000JPY
Increase decrease in notes and accounts payable trade ope cfPrior1YearDuration_NonConsolidatedMember4160000JPY
Increase decrease in notes and accounts payable trade ope cfCurrentYearDuration_NonConsolidatedMember-3426000JPY
Increase decrease in accounts payable other ope cfPrior1YearDuration_NonConsolidatedMember-6268000JPY
Increase decrease in accounts payable other ope cfCurrentYearDuration_NonConsolidatedMember5008000JPY
Other net ope cfPrior1YearDuration_NonConsolidatedMember-2669000JPY
Other net ope cfCurrentYearDuration_NonConsolidatedMember-22752000JPY
Subtotal ope cfPrior1YearDuration_NonConsolidatedMember97660000JPY
Subtotal ope cfCurrentYearDuration_NonConsolidatedMember65825000JPY
Interest and dividends income received ope cf inv cfPrior1YearDuration_NonConsolidatedMember3000JPY
Interest and dividends income received ope cf inv cfCurrentYearDuration_NonConsolidatedMember13000JPY
Interest expenses paid ope cf fin cfPrior1YearDuration_NonConsolidatedMember-136000JPY
Interest expenses paid ope cf fin cfCurrentYearDuration_NonConsolidatedMember-921000JPY
Income taxes paid ope cfPrior1YearDuration_NonConsolidatedMember-2011000JPY
Income taxes paid ope cfCurrentYearDuration_NonConsolidatedMember-67834000JPY
Net cash provided by used in operating activitiesPrior1YearDuration_NonConsolidatedMember95516000JPY
Net cash provided by used in operating activitiesCurrentYearDuration_NonConsolidatedMember-2917000JPY
Purchase of property plant and equipment inv cfPrior1YearDuration_NonConsolidatedMember-4632000JPY
Purchase of property plant and equipment inv cfCurrentYearDuration_NonConsolidatedMember-2269000JPY
Proceeds from sales of property plant and equipment inv cfPrior1YearDuration_NonConsolidatedMember51000JPY
Proceeds from sales of property plant and equipment inv cfCurrentYearDuration_NonConsolidatedMember－JPY
Purchase of intangible assets inv cfPrior1YearDuration_NonConsolidatedMember-12104000JPY
Purchase of intangible assets inv cfCurrentYearDuration_NonConsolidatedMember-114364000JPY
Purchase of investment securities inv cfPrior1YearDuration_NonConsolidatedMember－JPY
Purchase of investment securities inv cfCurrentYearDuration_NonConsolidatedMember-17118000JPY
Net cash provided by used in investment activitiesPrior1YearDuration_NonConsolidatedMember-16685000JPY
Net cash provided by used in investment activitiesCurrentYearDuration_NonConsolidatedMember-133751000JPY
Proceeds from long term loans payable fin cfPrior1YearDuration_NonConsolidatedMember300000000JPY
Proceeds from long term loans payable fin cfCurrentYearDuration_NonConsolidatedMember－JPY
Repayment of long term loans payable fin cfPrior1YearDuration_NonConsolidatedMember-11390000JPY
Repayment of long term loans payable fin cfCurrentYearDuration_NonConsolidatedMember-101876000JPY
Proceeds from issuance of common stock fin cfPrior1YearDuration_NonConsolidatedMember423880000JPY
Proceeds from issuance of common stock fin cfCurrentYearDuration_NonConsolidatedMember－JPY
Proceeds from issuance of stock resulting from exercise of subscription rights to shares fin cfPrior1YearDuration_NonConsolidatedMember26700000JPY
Proceeds from issuance of stock resulting from exercise of subscription rights to shares fin cfCurrentYearDuration_NonConsolidatedMember5900000JPY
Expenditure on initial public offering costs fin cfPrior1YearDuration_NonConsolidatedMember-11792000JPY
Expenditure on initial public offering costs fin cfCurrentYearDuration_NonConsolidatedMember－JPY
Repayments of lease obligations fin cfPrior1YearDuration_NonConsolidatedMember-1255000JPY
Repayments of lease obligations fin cfCurrentYearDuration_NonConsolidatedMember-1260000JPY
Purchase of treasury stock fin cfPrior1YearDuration_NonConsolidatedMember－JPY
Purchase of treasury stock fin cfCurrentYearDuration_NonConsolidatedMember-92049000JPY
Net cash provided by used in financing activitiesPrior1YearDuration_NonConsolidatedMember726142000JPY
Net cash provided by used in financing activitiesCurrentYearDuration_NonConsolidatedMember-189285000JPY
Net increase decrease in cash and cash equivalentsPrior1YearDuration_NonConsolidatedMember804973000JPY
Net increase decrease in cash and cash equivalentsCurrentYearDuration_NonConsolidatedMember-325954000JPY
Cash and cash equivalentsPrior2YearInstant_NonConsolidatedMember237395000JPY
Cash and cash equivalentsPrior1YearInstant_NonConsolidatedMember1042369000JPY
Cash and cash equivalentsPrior1YearInstant_NonConsolidatedMember1042369000JPY
Cash and cash equivalentsCurrentYearInstant_NonConsolidatedMember716414000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 13 of 13 passed
balance sheet identitynon_consolidated 2021-12-31pass rounding
balance sheet identitynon_consolidated 2022-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2020-12-31pass
statement vs summary · net assetsnon_consolidated 2021-12-31pass
statement vs summary · net assetsnon_consolidated 2022-12-31pass
statement vs summary · operating cash flownon_consolidated 2021-01-01/2021-12-31pass
statement vs summary · operating cash flownon_consolidated 2022-01-01/2022-12-31pass
statement vs summary · revenuenon_consolidated 2021-01-01/2021-12-31pass
statement vs summary · revenuenon_consolidated 2022-01-01/2022-12-31pass
statement vs summary · total assetsnon_consolidated 2021-12-31pass
statement vs summary · total assetsnon_consolidated 2022-12-31pass